The investigate relationship between severe neutropenia and ABCB1 and ABCG2 gene polymorphisms with esophageal cancer patients receiving docetaxel, cisplatin and 5-fluorouracil chemotherapy

被引：0
|
作者：
Nomura, H. [1 ]
Tsuji, D. [2 ]
Demachi, K. [1 ]
Suzuki, S. [1 ]
Mochizuki, N. [1 ]
Yano, T. [3 ]
Daiko, H. [4 ]
Fujii, S. [5 ]
Kojima, T. [6 ]
Ito, K. [2 ]
Yamaguchi, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Pharm, Kashiwa, Chiba, Japan
[2] Univ Shizuoka, Clin Phrmacol & Genet, Shizuoka, Japan
[3] Natl Canc Ctr Hosp East, Endoscopy Div, Gastroenterol, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr Hosp, Esophageal Surg, Chuo, Japan
[5] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Pathol, Kashiwa, Chiba, Japan
[6] Natl Canc Ctr Hosp East, Gastrointestinal Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1590P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Association between pharmacokinetic variables and neutropenia after treatment with docetaxel, cisplatin, and 5-fluorouracil in patients with esophageal squamous cell carcinoma
    Mitsuhiro Sugawara
    Chikatoshi Katada
    Toshiaki Komatsu
    Kaoru Takahashi
    Mizutomo Azuma
    Katsuhiko Higuchi
    Wasaburo Koizumi
    Koichiro Atsuda
    Esophagus, 2015, 12 : 209 - 218
  • [22] Association between pharmacokinetic variables and neutropenia after treatment with docetaxel, cisplatin, and 5-fluorouracil in patients with esophageal squamous cell carcinoma
    Sugawara, Mitsuhiro
    Katada, Chikatoshi
    Komatsu, Toshiaki
    Takahashi, Kaoru
    Azuma, Mizutomo
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Atsuda, Koichiro
    ESOPHAGUS, 2015, 12 (03) : 209 - 218
  • [23] Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
    Yu Ohkura
    Masaki Ueno
    Harushi Udagawa
    World Journal of Surgical Oncology, 17
  • [24] Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population
    Zeliha, Kara Pala
    Dilek, Ozturk
    Ezgi, Oztas
    Halil, Kara
    Cihan, Uras
    Gul, Ozhan
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (02) : 215 - 219
  • [25] Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
    Ohkura, Yu
    Ueno, Masaki
    Udagawa, Harushi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [26] Phase II study of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with node-positive esophageal cancer
    Watanabe, M.
    Nagai, Y.
    Iwagami, S.
    Miyamoto, Y.
    Hayashi, N.
    Baba, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] INFLUENCE OF ABCB1, ABCG2 AND MGMT PROMOTER METHYLATION AND GENE POLYMORPHISMS ON CLINICO-PATHOLOGICAL CHARACTERISTICS OF GLIOMA PATIENTS
    Oberstadt, M.
    Bien, S.
    Rimmbach, C.
    Weitmann, K.
    Vogelgesang, S.
    Zeden, J.
    Schroeder, H.
    Hoffmann, W.
    Rosskopf, D.
    Kroemer, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 333 - 333
  • [28] Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
    Loscocco, Federica
    Visani, Giuseppe
    Ruzzo, Annamaria
    Bagaloni, Irene
    Fuligni, Fabio
    Galimberti, Sara
    Di Paolo, Antonello
    Stagno, Fabio
    Pregno, Patrizia
    Annunziata, Mario
    Gozzini, Antonella
    Barulli, Sara
    Gabucci, Elisa
    Magnani, Mauro
    Isidori, Alessandro
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy
    Katsuhiko Nara
    Takehito Yamamoto
    Yasuyoshi Sato
    Koichi Yagi
    Koichiro Kawasaki
    Tetsuro Toriumi
    Tappei Takada
    Yasuyuki Seto
    Hiroshi Suzuki
    Supportive Care in Cancer, 2023, 31
  • [30] Efficacy and safety of docetaxel/cisplatin/5-fluorouracil preoperative combination chemotherapy in esophageal cancer patients with extended lymph node metastases
    Tanaka, Tsuyoshi
    Kinoshita, Yoshihiro
    Udagawa, Harushi
    Ueno, Masaki
    Ehara, Kazuhisa
    Haruta, Shusuke
    Kaida, Sachiko
    Nakagawa, Masatoshi
    ESOPHAGUS, 2012, 9 (02) : 99 - 104
12345